MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer

Experimental and Molecular Pathology

Volumn 99, Issue 1, 2015, Pages 173-179

  Lu, GuiFeng ^a   Sun, YaLing ^a   An, ShengLi ^a   Xin, SaiNan ^a   Ren, XiaoLi ^a   Zhang, Dan ^a   Wu, PingXiang ^a   Liao, WenTing ^a   Ding, YanQing ^a   Liang, Li ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; E2F5; FMNL2; MiR 34a; Progression

Indexed keywords

CELL PROTEIN; MICRORNA 34A; PROTEIN FMNL2; TRANSCRIPTION FACTOR E2F5; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; E2F5 PROTEIN, HUMAN; FMNL2 PROTEIN, HUMAN; MICRORNA; MIRN34 MICRORNA, HUMAN; PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE ARREST; CELL INVASION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN TARGETING; CELL CYCLE CHECKPOINT; COLORECTAL TUMOR; DISEASE COURSE; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; E2F5 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HT29 CELLS; HUMANS; MICRORNAS; PROTEINS;

EID: 84942928715     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2015.06.014     Document Type: Article

References (32)

1. Agostini M., et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:21093-21098.
2. Boysen J., et al. The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients. Leukemia 2014, 28:451-455.
3. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
4. Chang T.C., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 2007, 26:745-752.
5. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
6. Faix J., Grosse R. Staying in shape with formins. Dev. Cell 2006, 10:693-706.
7. Ishimoto T., et al. E2F5 as an independent prognostic factor in esophageal squamous cell carcinoma. Anticancer Res. 2013, 33:5415-5420.
8. Kitzing T.M., et al. Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC. Oncogene 2010, 29:2441-2448.
9. Kothandaraman N., et al. E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer. BMC Cancer 2010, 10:64.
10. Li Y., et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69:7569-7576.
11. Li Y.F., et al. FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Mol. Cancer Res. 2010, 8:1579-1590.
12. Liang L., et al. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2. Gastroenterology 2013, 144:624-635. (e4).
13. Liang J., et al. LEF1 targeting EMT in prostate cancer invasion is regulated by miR-34a. Mol. Cancer Res. 2015, 13:681-688.
14. Lodygin D., et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
15. McManus M.T. MicroRNAs and cancer. Semin. Cancer Biol. 2003, 13:253-258.
16. Nalls D., et al. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS One 2011, 6:e24099.
17. Nugent M., et al. Circulating miR-34a levels are reduced in colorectal cancer. J. Surg. Oncol. 2012, 106:947-952.
18. Peng Y., et al. MicroRNA-34A inhibits the growth, invasion and metastasis of gastric cancer by targeting PDGFR and MET expression. Biosci. Rep. 2014, 34.
19. Pritchard C.C., et al. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 2012, 13:358-369.
20. Ren X.L., et al. Down-regulation of BTG3 promotes cell proliferation, migration and invasion and predicts survival in gastric cancer. J. Cancer Res. Clin. Oncol. 2015, 141:397-405.
21. Shi Y., et al. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PLoS One 2014, 9:e90022.
22. Siemens H., et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011, 10:4256-4271.
23. Song B., Ju J. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev. Mol. Med. 2010, 12:e33.
24. Stracci F., et al. Colorectal cancer screening: tests, strategies, and perspectives. Front. Public Health 2014, 2:210.
25. Vogt M., et al. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch. 2011, 458:313-322.
26. Wu J., et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012, 33:519-528.
27. Yamakuchi M., et al. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13421-13426.
28. Yu G., et al. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44. J. Exp. Clin. Cancer Res. 2014, 33:779.
29. Zhao J., et al. Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer. Med. Oncol. 2013, 30.
30. Zhou M.K., et al. MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells. Mol. Med. Rep. 2015, 11:2947-2952.
31. Zhu X.L., et al. FMNL2 is a positive regulator of cell motility and metastasis in colorectal carcinoma. J. Pathol. 2011, 224:377-388.
32. Zou C.C., et al. Up-regulated MicroRNA-181a induces carcinogenesis in Hepatitis B virus-related hepatocellular carcinoma by targeting E2F5. BMC Cancer 2014, 14.